Fetal Neurobehavior in Poly-drug Dependent Women
NCT00653692 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2013-02-21
Summary
This project examines fetal neurobehavior and maternal physiology in poly-drug dependent women. This study also evaluates infant neonatal abstinence syndrome, infant neurobehavior and vagal tone in the post-partum period.
Conditions
- Poly Drug Exposed Pregnancies
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
Lauren M Jansson, MD · Johns Hopkins University
Eligibility
- Min Age
- 18 Years
- Max Age
- 41 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2010-02-28
- Completion
- 2010-08-31
Countries
- United States
Study Locations
More Related Trials
-
Neonatal and Maternal Effects of Buprenorphine and Methadone
NCT03024736 ·Status: COMPLETED
-
Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their Mothers
NCT01889121 ·Status: COMPLETED
-
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
NCT05942313 ·Status: RECRUITING
-
Tobacco Use in Opioid Agonist Treated Pregnant Women
NCT00497068 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Maternal Brain Imaging in Opioid Use Disorder
NCT06008990 ·Status: COMPLETED
-
Treatment Education for Perinatal Women and Their Community Support
NCT06733649 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome
NCT03334981 ·Status: COMPLETED
-
Treating the Partners of Drug Using Pregnant Women: Stage II
NCT00496990 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
NCT06999811 ·Status: RECRUITING ·Phase: NA
-
Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2
NCT00218010 ·Status: COMPLETED
-
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
NCT03911466 ·Status: COMPLETED
-
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
NCT04939012 ·Status: RECRUITING ·Phase: NA
-
Opioid Dependence Treatment Therapies in Pregnancy
NCT03098407 ·Status: COMPLETED ·Phase: NA
-
RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants
NCT02178189 ·Status: COMPLETED ·Phase: PHASE2
-
Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People
NCT06496230 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Piloting a Web Resource for Pregnancy OUD in Jail
NCT05853289 ·Status: COMPLETED ·Phase: NA
-
Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse
NCT00292123 ·Status: COMPLETED ·Phase: PHASE1
-
Reinforcement-Based Treatment for Pregnant Drug Abusers
NCT01177982 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Improving Effective Contraceptive Use Among Opioid-maintained Women
NCT01425060 ·Status: COMPLETED ·Phase: PHASE1
-
Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine
NCT04611659 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Buprenorphine and Methadone - 3
NCT00000334 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)
NCT02794597 ·Status: COMPLETED ·Phase: NA
-
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
NCT01416584 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Maintenance for Opioid Addicts - 1
NCT00000202 ·Status: COMPLETED ·Phase: PHASE2
-
CYP2B6 Polymorphisms in Methadone Disposition
NCT01648283 ·Status: COMPLETED ·Phase: NA